Machine learning–based identification and ranking of risk factors for lumbar paraspinal muscle atrophy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing Machine Learning to Identify and Prioritize Risk Factors for Atrophy of Lumbar Paraspinal Muscles

  • By

  • Lukas Schönnagel

  • Tom Folkerts

  • Ali Guven

  • Erika Chiapparelli

  • Jiaqi Zhu

  • Gaston Camino-Willhuber

  • Thomas Caffard

  • Artine Arzani

  • Paul Köhli

  • Marco D. Burkhard

  • Jennifer Shue

  • Andrew A. Sama

  • Federico P. Girardi

  • Frank P. Cammisa

  • Alexander P. Hughes

  • March 28, 2026

Share

Original Source(s)

Machine learning–based identification and ranking of risk factors for lumbar paraspinal muscle atrophy

  • by Lukas Schönnagel, Tom Folkerts, Ali Guven, Erika Chiapparelli, Jiaqi Zhu, Gaston Camino-Willhuber, Thomas Caffard, Artine Arzani, Paul Köhli, Marco D. Burkhard, Jennifer Shue, Andrew A. Sama, Federico P. Girardi, Frank P. Cammisa, Alexander P. Hughes

  • March 28, 2026

Related Content

Medical Oddities: Could GLP-1s Curb Violence?

Five studies, one question: are we overlooking hidden drivers of health?

Top 10 States for Physician-Owned Hospitals

These 10 states make it more practical for physicians to participate in hospital ownership by aligning statutory structure, corporate practice of medicine rules, and population trends.

FDA Okays Weekly Option in Achondroplasia

Navepegritide is described as the first therapy to deliver continuous C-type natriuretic peptide exposure over a weekly dosing interval in eligible pediatric patients.